| Issue Date | Title | Involved Person(s) |
| 2024 | Suicidality emerging from rapid Venlafaxine discontinuation | Kostic, Milutin; Plöderl, Martin; Hengartner, Michael; Buzejic, Jelena |
| Sep-2023 | Re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder" by Strawn et al. : concerning harm-benefit ratio in a recent trial about Escitalopram for generalized anxiety disorder | Plöderl, Martin; Horowitz, Mark A.; Hengartner, Michael P. |
| 16-Jun-2023 | The serotonin hypothesis of depression : both long discarded and still supported? | Moncrieff, Joanna; Cooper, Ruth E.; Stockmann, Tom; Amendola, Simone; Hengartner, Michael P., et al |
| 9-Feb-2023 | No clear evidence of reduced brain serotonin release capacity in patients with depression | Hengartner, Michael P.; Plöderl, Martin |
| 2022 | Suizidpräventive Effekte von Ketamin und Esketamin | Plöderl, Martin; Hengartner, Michael P.; Volkmann, Constantin |
| 8-Nov-2021 | Learning about the course of suicidal behavior but not about the effects of SSRIs | Plöderl, Martin; Hengartner, Michael Pascal |
| 2020 | Commentary to “antidepressants and suicidality : a re-analysis of the re-analysis” | Plöderl, Martin; Hengartner, Michael Pascal; Bschor, Tom; Kaminski, Jakob André |
| Nov-2019 | Wirken Antidepressiva bei schweren Depressionen besser als bei leichten? | Hengartner, Michael Pascal; Plöderl, Martin |
| Jun-2019 | Antidepressiva wirken! Oder doch nicht? | Plöderl, Martin; Hengartner, Michael Pascal |
| 2018 | Starting two antidepressants to prevent suicide : a potentially dangerous recommendation? | Hengartner, Michael Pascal; Plöderl, Martin |
